Nikolaos S. Avramiotis
YOU?
Author Swipe
View article: Misleading detection of herpes simplex virus type 1 in a patient with paraneoplastic encephalitis
Misleading detection of herpes simplex virus type 1 in a patient with paraneoplastic encephalitis Open
Encephalitis is a potentially life-threatening condition with infectious or autoimmune aetiologies. Autoimmune encephalitis includes paraneoplastic variants associated with specific onconeural antibodies such as anti-Hu, frequently linked …
View article: Antithrombotic drugs for carotid artery dissection: Updated systematic review
Antithrombotic drugs for carotid artery dissection: Updated systematic review Open
Introduction: Extracranial internal carotid artery dissection (eICAD) is a leading cause of stroke in younger patients. In this Cochrane Review update we compared benefits and harms of eICAD-patients treated with either antiplatelets or an…
View article: Tranexamic Acid for Intracerebral Hemorrhage in Patients on Non-Vitamin K Antagonist Oral Anticoagulants (TICH-NOAC): A Multicenter, Randomized, Placebo-Controlled, Phase 2 Trial
Tranexamic Acid for Intracerebral Hemorrhage in Patients on Non-Vitamin K Antagonist Oral Anticoagulants (TICH-NOAC): A Multicenter, Randomized, Placebo-Controlled, Phase 2 Trial Open
BACKGROUND: Evidence-based hemostatic treatment for intracerebral hemorrhage (ICH) associated with non–vitamin K antagonist oral anticoagulants (NOACs) is lacking. Tranexamic acid (TXA) is an antifibrinolytic drug potentially limiting hema…
View article: Once versus twice daily direct oral anticoagulants in patients with recent stroke and atrial fibrillation
Once versus twice daily direct oral anticoagulants in patients with recent stroke and atrial fibrillation Open
Background: Data on the safety and effectiveness of once-daily (QD) versus twice-daily (BID) direct oral anticoagulants (DOAC) in comparison to vitamin K antagonists (VKA) and to one another in patients with atrial fibrillation (AF) and re…
View article: Oral Anticoagulants in the Oldest Old with Recent Stroke and Atrial Fibrillation
Oral Anticoagulants in the Oldest Old with Recent Stroke and Atrial Fibrillation Open
Objective To investigate the safety and effectiveness of direct oral anticoagulants (DOAC) versus vitamin K antagonists (VKA) after recent stroke in patients with atrial fibrillation (AF) aged ≥85 years. Methods Individual patient data ana…